Quick Heal Technologies Ltd (QUICKHEAL) Q4FY26 Concall Summary - Mar-2026 Qtr
Performance Overview
- The company is undergoing a significant transformation from a B2C anti-virus provider to a holistic B2B cybersecurity company, which has led to short-term financial pressure, including the worst quarter in terms of profitability in its history.
- The Enterprise business has grown to become the major contributor, now representing over 50% of the top line, compensating for the de-growth in the consumer segment.
- The consumer business continues to face significant headwinds due to a broader industry slowdown and a temporary shift in channel partner focus towards hardware, which saw price inflation of up to 400%.
- Management has implemented tighter credit controls with channel partners to address rising overdues, which impacted the top line but successfully reduced outstanding dues from a peak of INR 176 crores to INR 138 crores.
- Despite the current financial losses, the company maintains a strong, debt-free balance sheet with cash and investments of INR 224 crores at year-end, providing the flexibility to continue investing in R&D and market expansion.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.